COVID-19 Management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases Centre: A Retrospective Analysis

Recent large national and international cohorts describe the baseline characteristics and outcome of hospitalised patients with COVID-19, however there is limited granularity to these reports. We aimed to provide a detailed description of a UK COVID-19 cohort, focusing on management and outcome. We...

Full description

Bibliographic Details
Main Authors: Kenneth F. Baker, Aidan T. Hanrath, Ina Schim van der Loeff, Su Ann Tee, Richard Capstick, Gabriella Marchitelli, Ang Li, Andrew Barr, Alsafi Eid, Sajeel Ahmed, Dalvir Bajwa, Omer Mohammed, Neil Alderson, Clare Lendrem, Dennis W. Lendrem, COVID-19 Control Group, COVID-19 Clinical Group, Lucia Pareja-Cebrian, Andrew Welch, Joanne Field, Brendan A. I. Payne, Yusri Taha, David A. Price, Christopher Gibbins, Matthias L. Schmid, Ewan Hunter, Christopher J. A. Duncan
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Medical Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3271/9/1/6
_version_ 1827603620802068480
author Kenneth F. Baker
Aidan T. Hanrath
Ina Schim van der Loeff
Su Ann Tee
Richard Capstick
Gabriella Marchitelli
Ang Li
Andrew Barr
Alsafi Eid
Sajeel Ahmed
Dalvir Bajwa
Omer Mohammed
Neil Alderson
Clare Lendrem
Dennis W. Lendrem
COVID-19 Control Group
COVID-19 Clinical Group
Lucia Pareja-Cebrian
Andrew Welch
Joanne Field
Brendan A. I. Payne
Yusri Taha
David A. Price
Christopher Gibbins
Matthias L. Schmid
Ewan Hunter
Christopher J. A. Duncan
author_facet Kenneth F. Baker
Aidan T. Hanrath
Ina Schim van der Loeff
Su Ann Tee
Richard Capstick
Gabriella Marchitelli
Ang Li
Andrew Barr
Alsafi Eid
Sajeel Ahmed
Dalvir Bajwa
Omer Mohammed
Neil Alderson
Clare Lendrem
Dennis W. Lendrem
COVID-19 Control Group
COVID-19 Clinical Group
Lucia Pareja-Cebrian
Andrew Welch
Joanne Field
Brendan A. I. Payne
Yusri Taha
David A. Price
Christopher Gibbins
Matthias L. Schmid
Ewan Hunter
Christopher J. A. Duncan
author_sort Kenneth F. Baker
collection DOAJ
description Recent large national and international cohorts describe the baseline characteristics and outcome of hospitalised patients with COVID-19, however there is limited granularity to these reports. We aimed to provide a detailed description of a UK COVID-19 cohort, focusing on management and outcome. We performed a retrospective single-centre analysis of clinical management and 28-day outcomes of consecutive adult inpatients with SARS-CoV-2 PCR-confirmed COVID-19 from 31 January to 16 April 2020 inclusive. In total, 316 cases were identified. Most patients were elderly (median age 75) with multiple comorbidities. One quarter were admitted from residential or nursing care. Mortality was 84 out of 316 (26.6%). Most deaths occurred in patients in whom a ceiling of inpatient treatment had been determined and for whom end of life care and specialist palliative care input was provided where appropriate. No deaths occurred in patients aged under 56 years. Decisions to initiate respiratory support were individualised after consideration of patient wishes, premorbid frailty and comorbidities. In total, 59 (18%) patients were admitted to intensive care, of which 31 (10% overall cohort) required intubation. Multiple logistic regression identified associations between death and age, frailty, and disease severity, with age as the most significant factor (odds ratio 1.07 [95% CI 1.03–1.10] per year increase, <i>p</i> < 0.001). These findings provide important clinical context to outcome data. Mortality was associated with increasing age. Most deaths were anticipated and occurred in patients with advance decisions on ceilings of treatment.
first_indexed 2024-03-09T05:43:18Z
format Article
id doaj.art-870b230cba944667b97b082405b7389c
institution Directory Open Access Journal
issn 2076-3271
language English
last_indexed 2024-03-09T05:43:18Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Medical Sciences
spelling doaj.art-870b230cba944667b97b082405b7389c2023-12-03T12:23:24ZengMDPI AGMedical Sciences2076-32712021-02-0191610.3390/medsci9010006COVID-19 Management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases Centre: A Retrospective AnalysisKenneth F. Baker0Aidan T. Hanrath1Ina Schim van der Loeff2Su Ann Tee3Richard Capstick4Gabriella Marchitelli5Ang Li6Andrew Barr7Alsafi Eid8Sajeel Ahmed9Dalvir Bajwa10Omer Mohammed11Neil Alderson12Clare Lendrem13Dennis W. Lendrem14COVID-19 Control GroupCOVID-19 Clinical GroupLucia Pareja-Cebrian15Andrew Welch16Joanne Field17Brendan A. I. Payne18Yusri Taha19David A. Price20Christopher Gibbins21Matthias L. Schmid22Ewan Hunter23Christopher J. A. Duncan24Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UKTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UKTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKNIHR In Vitro Diagnostics Cooperative, Newcastle University, Newcastle upon Tyne NE2 4HH, UKNational Institute of Health Research (NIHR) Newcastle Biomedical Research Centre, Newcastle University and The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE2 4HH, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, UKTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UKRecent large national and international cohorts describe the baseline characteristics and outcome of hospitalised patients with COVID-19, however there is limited granularity to these reports. We aimed to provide a detailed description of a UK COVID-19 cohort, focusing on management and outcome. We performed a retrospective single-centre analysis of clinical management and 28-day outcomes of consecutive adult inpatients with SARS-CoV-2 PCR-confirmed COVID-19 from 31 January to 16 April 2020 inclusive. In total, 316 cases were identified. Most patients were elderly (median age 75) with multiple comorbidities. One quarter were admitted from residential or nursing care. Mortality was 84 out of 316 (26.6%). Most deaths occurred in patients in whom a ceiling of inpatient treatment had been determined and for whom end of life care and specialist palliative care input was provided where appropriate. No deaths occurred in patients aged under 56 years. Decisions to initiate respiratory support were individualised after consideration of patient wishes, premorbid frailty and comorbidities. In total, 59 (18%) patients were admitted to intensive care, of which 31 (10% overall cohort) required intubation. Multiple logistic regression identified associations between death and age, frailty, and disease severity, with age as the most significant factor (odds ratio 1.07 [95% CI 1.03–1.10] per year increase, <i>p</i> < 0.001). These findings provide important clinical context to outcome data. Mortality was associated with increasing age. Most deaths were anticipated and occurred in patients with advance decisions on ceilings of treatment.https://www.mdpi.com/2076-3271/9/1/6treatment escalationventilationintubationSARS-CoV-2mortality
spellingShingle Kenneth F. Baker
Aidan T. Hanrath
Ina Schim van der Loeff
Su Ann Tee
Richard Capstick
Gabriella Marchitelli
Ang Li
Andrew Barr
Alsafi Eid
Sajeel Ahmed
Dalvir Bajwa
Omer Mohammed
Neil Alderson
Clare Lendrem
Dennis W. Lendrem
COVID-19 Control Group
COVID-19 Clinical Group
Lucia Pareja-Cebrian
Andrew Welch
Joanne Field
Brendan A. I. Payne
Yusri Taha
David A. Price
Christopher Gibbins
Matthias L. Schmid
Ewan Hunter
Christopher J. A. Duncan
COVID-19 Management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases Centre: A Retrospective Analysis
Medical Sciences
treatment escalation
ventilation
intubation
SARS-CoV-2
mortality
title COVID-19 Management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases Centre: A Retrospective Analysis
title_full COVID-19 Management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases Centre: A Retrospective Analysis
title_fullStr COVID-19 Management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases Centre: A Retrospective Analysis
title_full_unstemmed COVID-19 Management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases Centre: A Retrospective Analysis
title_short COVID-19 Management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases Centre: A Retrospective Analysis
title_sort covid 19 management in a uk nhs foundation trust with a high consequence infectious diseases centre a retrospective analysis
topic treatment escalation
ventilation
intubation
SARS-CoV-2
mortality
url https://www.mdpi.com/2076-3271/9/1/6
work_keys_str_mv AT kennethfbaker covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT aidanthanrath covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT inaschimvanderloeff covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT suanntee covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT richardcapstick covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT gabriellamarchitelli covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT angli covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT andrewbarr covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT alsafieid covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT sajeelahmed covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT dalvirbajwa covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT omermohammed covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT neilalderson covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT clarelendrem covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT denniswlendrem covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT covid19controlgroup covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT covid19clinicalgroup covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT luciaparejacebrian covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT andrewwelch covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT joannefield covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT brendanaipayne covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT yusritaha covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT davidaprice covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT christophergibbins covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT matthiaslschmid covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT ewanhunter covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis
AT christopherjaduncan covid19managementinauknhsfoundationtrustwithahighconsequenceinfectiousdiseasescentrearetrospectiveanalysis